• Genes and health
• Conditions we cover
• Ovarian Cancer
• Complete scan
• Cancer scan
• Cardio scan
• Advanced features

Knowing your genetic risk of ovarian cancer may alert you earlier to any possible symptoms of the disease.

If diagnosed early, treatment for ovarian cancer can be very effective with up to 90% of women surviving for more than five years.

Prevent ovarian cancer by knowing your risk and recognizing the symptoms

Ovarian cancer is often referred to as a “silent killer”, because it can develop silently (without symptoms) until the disease has advanced and spread to an extent that the chance of cure or remission is poor.

Although mild and often general in nature, symptoms of ovarian cancer are persistent and represent a feeling of change from what women consider their body´s normal state. Recognizing these symptoms and reporting them to your doctor or healthcare provider are key factors for an early diagnosis of ovarian cancer.

Possible signs and symptoms of ovarian cancer

• Bloating or abdominal swelling – when the area below the stomach swells or feels full and clothes become too tight.
• Pelvic pain or pressure in the pelvic or abdominal area
• Back pain
• Fatigue – feeling tired all the time
• Urinary problems or a change in urinary habits, for example increased urgency, burning, or spasms when urinating
• Digestive symptoms such as gas, indigestion, heartburn, nausea, or changes in bowel movements
• Vaginal discharge or bleeding that is not normal for you, especially if your are past menopause

These symptoms may also be caused by something other than ovarian cancer, but the only way to know is to see your doctor or healthcare provider.

Knowing your genetic risk of ovarian cancer can be your first step toward better prevention

Knowing your genetic risk of ovarian cancer may alert you earlier to any possible symptoms. If diagnosed early, treatment for ovarian cancer can be very effective with up to 90% of women surviving for more than five years.

The deCODEme Complete Scan identifies a recently discovered, common genetic variant in the 9p22.2 region and uses it to provide female customers of European descent with a personalized interpretation of their genetic risk for developing ovarian cancer.

At present, the necessary scientific information to interpret the genetic risk for women of other ethnicities is not available. This information will be added as soon as it becomes available and we are assured of its quality.

This content was last reviewed on February 09, 2010.

The conditions we cover: ABO Blood Types, Abdominal Aortic Aneurysm, Age Related Macular Degeneration, Alcohol Flush Reaction, Alzheimer’s Disease, Asthma, Atrial Fibrillation, Basal Cell Carcinoma, Bitter Taste Perception, Bladder Cancer, Brain Aneurysm, Brain Cancer-Glioma, Breast Cancer, Celiac Disease, Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Colorectal Cancer, Crohn’s Disease, Essential Tremor, Exfoliation Glaucoma, Eye Color, Gallstones, Gout, Heart Attack, Hemochromatosis, Hypertension, Kidney Stones, Lactose Intolerance, Lung Cancer, Male Pattern Baldness, Multiple Sclerosis, Nicotine Dependence, Obesity, Ovarian Cancer, Pancreatic Cancer, Peripheral Arterial Disease, Prostate Cancer, Psoriasis, Restless Legs Syndrome, Rheumatoid Arthritis, Statin Induced Myopathy, Systemic Lupus Erythematosus, Testicular Cancer, Thyroid Cancer, Type 1 Diabetes, Type 2 Diabetes, Ulcerative Colitis, Venous Thromboembolism, Warfarin Metabolism.